Pharma-nutrition tie-ups race to capture $150B GLP-1 companion market
As Wegovy and Mounjaro enter India and semaglutide generics loom, global pharma is partnering with Nestle, Abbott and Danone on GLP-1 companion protein and micronutrient products. Indian nutraceutical and food brands are expected to follow, opening a new white-space category projected at $150B by early 2030s.
Pharma firms are partnering with nutrition players to build GLP-1 companion products (protein shakes, fortified meals). With Mounjaro and Wegovy entering India and semaglutide generics looming, Indian nutraceutical and food brands are expected to launch GLP-1-aligned protein and micronutrient products.
Also reported by
- Moneycontrol · Results — 1h after first sighting